Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies

P. L. Beaumier, D. Neuzil, H. M. Yang, E. A. Noll, R. Kishore, J. F. Eary, Kenneth Krohn, W. B. Nelp, K. E. Hellström, I. Hellström

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

A convenient, rapid, and reproducible assay was developed to evaluate the immunoreactivity of radiolabeled monoclonal antibodies against three different human melanoma-associated antigens, p97, a proteoglycan and a GD3 ganglioside. A cloned melanoma cell line (M 2669 CL13) was selected as the target and, when fixed with paraformaldehyde, showed binding as good as or better than that obtained with live cells for the three antigens. Fixed cells retained good binding properties stored at 4°C for over 6 mo. This assay has general applicability to other antigen-antibody systems for testing chemically modified monoclonal antibodies or fragments during the development of a radiopharmaceutical or as a routine quality control measure for clinical agents.

Original languageEnglish (US)
Pages (from-to)824-828
Number of pages5
JournalJournal of Nuclear Medicine
Volume27
Issue number6
StatePublished - 1986
Externally publishedYes

Fingerprint

Melanoma
Monoclonal Antibodies
Antigens
Immunoglobulin Fragments
Radiopharmaceuticals
Proteoglycans
Quality Control
Cell Line
Antibodies
human melanotransferrin protein
paraform
GD3 ganglioside

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Beaumier, P. L., Neuzil, D., Yang, H. M., Noll, E. A., Kishore, R., Eary, J. F., ... Hellström, I. (1986). Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies. Journal of Nuclear Medicine, 27(6), 824-828.

Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies. / Beaumier, P. L.; Neuzil, D.; Yang, H. M.; Noll, E. A.; Kishore, R.; Eary, J. F.; Krohn, Kenneth; Nelp, W. B.; Hellström, K. E.; Hellström, I.

In: Journal of Nuclear Medicine, Vol. 27, No. 6, 1986, p. 824-828.

Research output: Contribution to journalArticle

Beaumier, PL, Neuzil, D, Yang, HM, Noll, EA, Kishore, R, Eary, JF, Krohn, K, Nelp, WB, Hellström, KE & Hellström, I 1986, 'Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies', Journal of Nuclear Medicine, vol. 27, no. 6, pp. 824-828.
Beaumier PL, Neuzil D, Yang HM, Noll EA, Kishore R, Eary JF et al. Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies. Journal of Nuclear Medicine. 1986;27(6):824-828.
Beaumier, P. L. ; Neuzil, D. ; Yang, H. M. ; Noll, E. A. ; Kishore, R. ; Eary, J. F. ; Krohn, Kenneth ; Nelp, W. B. ; Hellström, K. E. ; Hellström, I. / Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies. In: Journal of Nuclear Medicine. 1986 ; Vol. 27, No. 6. pp. 824-828.
@article{d799ce68ae074ee791be7145a83690ea,
title = "Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies",
abstract = "A convenient, rapid, and reproducible assay was developed to evaluate the immunoreactivity of radiolabeled monoclonal antibodies against three different human melanoma-associated antigens, p97, a proteoglycan and a GD3 ganglioside. A cloned melanoma cell line (M 2669 CL13) was selected as the target and, when fixed with paraformaldehyde, showed binding as good as or better than that obtained with live cells for the three antigens. Fixed cells retained good binding properties stored at 4°C for over 6 mo. This assay has general applicability to other antigen-antibody systems for testing chemically modified monoclonal antibodies or fragments during the development of a radiopharmaceutical or as a routine quality control measure for clinical agents.",
author = "Beaumier, {P. L.} and D. Neuzil and Yang, {H. M.} and Noll, {E. A.} and R. Kishore and Eary, {J. F.} and Kenneth Krohn and Nelp, {W. B.} and Hellstr{\"o}m, {K. E.} and I. Hellstr{\"o}m",
year = "1986",
language = "English (US)",
volume = "27",
pages = "824--828",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "6",

}

TY - JOUR

T1 - Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies

AU - Beaumier, P. L.

AU - Neuzil, D.

AU - Yang, H. M.

AU - Noll, E. A.

AU - Kishore, R.

AU - Eary, J. F.

AU - Krohn, Kenneth

AU - Nelp, W. B.

AU - Hellström, K. E.

AU - Hellström, I.

PY - 1986

Y1 - 1986

N2 - A convenient, rapid, and reproducible assay was developed to evaluate the immunoreactivity of radiolabeled monoclonal antibodies against three different human melanoma-associated antigens, p97, a proteoglycan and a GD3 ganglioside. A cloned melanoma cell line (M 2669 CL13) was selected as the target and, when fixed with paraformaldehyde, showed binding as good as or better than that obtained with live cells for the three antigens. Fixed cells retained good binding properties stored at 4°C for over 6 mo. This assay has general applicability to other antigen-antibody systems for testing chemically modified monoclonal antibodies or fragments during the development of a radiopharmaceutical or as a routine quality control measure for clinical agents.

AB - A convenient, rapid, and reproducible assay was developed to evaluate the immunoreactivity of radiolabeled monoclonal antibodies against three different human melanoma-associated antigens, p97, a proteoglycan and a GD3 ganglioside. A cloned melanoma cell line (M 2669 CL13) was selected as the target and, when fixed with paraformaldehyde, showed binding as good as or better than that obtained with live cells for the three antigens. Fixed cells retained good binding properties stored at 4°C for over 6 mo. This assay has general applicability to other antigen-antibody systems for testing chemically modified monoclonal antibodies or fragments during the development of a radiopharmaceutical or as a routine quality control measure for clinical agents.

UR - http://www.scopus.com/inward/record.url?scp=0022911183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022911183&partnerID=8YFLogxK

M3 - Article

C2 - 3712094

AN - SCOPUS:0022911183

VL - 27

SP - 824

EP - 828

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 6

ER -